Navigation Links
Exploring new pathways to language
Date:2/17/2009

When ABC journalist Bob Woodruff was injured while reporting in Iraq in 2006, he suffered severe head injuries that caused him to lose his ability to recall and produce common words a condition called aphasia. Today, Woodruff has recovered most of his language skills thanks to intensive behavioral therapy reading and repeating words and sounds.

"The standard of care for patients with aphasia has always been and will always be speech/language therapy, but a new area is opening up that looks at what drugs can be used in combination with therapy to enhance recovery from brain damage and help the brain repair itself," said Gerry Stefanatos, D.Phil., an associate professor of communication sciences and disorders in the College of Health Professions. "We're looking at the mechanism of how this combination works it's underlying effect on patients with aphasia."

In research presented at the International Neurological Society this month, Stefanatos found that dextroamphetamine (D-AMPH), a drug commonly used to treat attention deficit hyperactivity disorder, improved the processing of speech among those suffering from Broca's aphasia and the similar Anomic aphasia.

"Improving a patient's attention and working memory may allow them to better focus and process information during therapy sessions," said Stefanatos. "Attention is critically important for learning and relearning skills, and could be helpful in forging new neural pathways in the brain."

The National Aphasia Association estimates some one million people in the United States live with aphasia, which is caused by lesions to the language centers of the brain. These lesions are often due to stroke or brain injury, but can also be the result of a brain tumor or progressive disease such as Parkinson's or Alzheimer's. Types of aphasia can range from a patient having difficulty finding and producing a word to a patient having no ability at all to speak or understand language.

Stefanatos' study looked at the use of D-AMPH in ten aphasia patients. All were also given a placebo for comparison purposes. In each condition, participants were asked to make decisions about different types of speech sounds (vowels, consonant-vowels) and complex tones. Their brain's electrical response to each was recorded via an electroencephalogram (EEG).

Those who took the D-AMPH had a strong reaction to the sounds even to consonant-vowel sounds, which are more often difficult for individuals with aphasia to process.

"This tells us that D-AMPH may help the left hemisphere of the brain regain the ability to perform its functions," said Stefanatos. "Understanding why the drug is having this effect allows us to start to think about how to tailor treatments to make them more effective or explore alternative drugs or drug combinations."

Stefanatos said he and his team chose to look at this particular drug because in patients with ADHD it has been shown to stimulate the release of dopamine and epinephrine, which help in attention and learning. But he notes that some people aren't good candidates for this particular drug.

"Now that we have a rudimentary understanding of why the drug may work to enhance the results of therapy, our next step is to look at dose effects and perhaps other drugs with more favorable side effect profiles," said Stefanatos.

Stefanatos will next study functional magnetic resonance imaging to explore the effects of D-AMPH on cerebral metabolism and where in the brain of individuals with aphasia it has the greatest effect.


'/>"/>

Contact: Renee Cree
renee.cree@temple.edu
215-707-1583
Temple University
Source:Eurekalert  

Related medicine news :

1. NIH grant supports UCSF research exploring early HIV infection
2. Exploring the Use of Techniques From Neuroscience in Todays Marketing
3. Blue Cross Blue Shield of Michigan Foundation Funds Study Exploring Link between Heart Disease and Depression
4. Exploring the Aaah ... $1 Million Grant Advances Aquatic Health Research
5. Exploring the Frontiers of Neuroscience
6. Scientists exploring new compounds to target muscular dystrophy
7. Exploring Genetic Link Between Migraines, Cardiovascular Trouble
8. Different Neural Pathways at Work Going Under, Coming Out of Anesthesia
9. Georgetown researchers find stem cell marker controls 2 key cancer pathways
10. Stem Cell Marker Controls Pair of Key Cancer Pathways
11. Breast cancer subtypes originate from different biological pathways
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Exploring new pathways to language
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: